Teresa Ghilarducci, PhD, holds the Bernard L. and Irene Schwartz Chair in economic policy analysis at The New School for Social Research.

Jonathan W. Simons is an American physician-scientist, medical oncologist, and leader in prostate cancer research. Simons is the Chief Science Officer and Medical Director of the Marcus Foundation.

A world-renowned geriatrician and epidemiologist, Linda Fried has defined frailty and its causes, conducted research on the prevention of disability and cardiovascular disease, and proposes that investments in health for longer lives could build a Third Demographic Dividend.

Richard Merkin is the CEO and founder of the Heritage Group. Under his stewardship, the Heritage Group has become the largest, physician-owned and -operated integrated delivery system in the United States with more than 50 related health-care companies.

Shmuel Meitar is the founder of Time to Know, the first comprehensive digital teaching platform. He established Time to Know in 2004 as a philanthropic endeavor in Israel and expanded it into an international business.

Ken Dychtwald is president and CEO of Age Wave, a firm that guides companies and government groups in product/service development for baby boomers and mature adults. He has dedicated his life to battling ageist stereotypes while promoting a new, vital and purposeful role for life’s second half.

Mark McClellan is the Robert J. Margolis Professor of Business, Medicine, and Policy, and founding director of the Duke-Margolis Center for Health Policy at Duke University. McClellan is a doctor and an economist who has addressed a wide range of strategies and policy reforms to improve health care, including payment reform to promote better outcomes and lower costs, methods for development and use of real-world evidence, and strategies for more effective biomedical innovation.

Dr. Michelle Longmire is mission-driven to accelerate the development of new therapies for disease as the founder and Chief Executive Officer of Medable. A Stanford-trained physician-scientist, Dr. Longmire identified critical barriers to drug development and founded Medable to pioneer a new category of clinical trial technologies that remove traditional roadblocks to participation and radically accelerate the research process.

Joseph Coughlin is founder and director of the Massachusetts Institute of Technology AgeLab. He teaches in MIT's Department of Urban Studies & Planning and the Sloan School's Advanced Management Program.

Pinchas Cohen, MD, is the dean of the USC Leonard Davis School of Gerontology at the University of Southern California.